Table 2.

Literature review findings of multilevel resilience resources among Persons Living With HIV (PLWH) on HIV-related health behaviors and outcomes

First Author, Year	How Was Resilience Defined?	What was the adversity?	Research Design (Longitudinal, Cross-Sectional)	Location	Sample	Resilience is independent or other variable	Resilience Measure	Level of Resilience Resource	HIV Health Behavior or Health Outcome	Key findings between resilience & outcome measure
Solano, et al. (1993)	Resilience not specifically mentioned, however, the article refers to personality features (i.e., fighting spirit or positive mood) in relation to chronic disease survival	Living with HIV	Longitudinal	Italy	100 PLWH; 74 males and 26 females;	IV	Social support: Social Support Scale; Hardiness: Hardiness Scale; Psychological Attitudes - Fighting Sprit using three stories	ML (I, Int)	Clinical Evolution (i.e., unchanged/symptomatic): CD4 obtained from blood samples	At 12 months, fighting spirit was higher in unchanged participants. There was an interaction between immunological factors and hardiness control subscale scores such that low hardiness was higher in symptomatics who had low CD4 at baseline.
Friedman, et al. (2016)	Resilience mentioned but not defined	Living with HIV, psychosocial syndemics (e.g., depression, condomless sex)	Longitudinal	USA, Illinois, Pennsylvania, California, Maryland	712 PLWH; 100% male; 14.9% Hispanic, 59.3% White, 24.7% Black	IV, moderator	Social support- Functional Social Support	Int	Viral load: Obtained from blood draws	Compared to men with low levels of social support, men with medium and high levels of social support had lower viral loads and were more likely to have viral load suppression. Social support moderated the effects of syndemic indicators on higher viral load; among this subgroup, those reporting higher social support had more viral suppression over time.
Simoni MJ, et al. (2002)	NR	Living with HIV	Cross-sectional	USA,New York	50 PLWH; 31 women and 19 men; 52% African American (52%) and 30% or Puerto Rican	IV and mediator	Social Support: Modified UCLA Social Support Inventory; Self-efficacy: Self-efficacy to adhere to prescribed medications.	ML (I, Int)	ART adherence: AACTG medication adherence and a self-report measure of acknowledged nonadherence	Receipt of social support was not associaed with adherence, thus examination of self-efficacy as a mediator of this relationship was not conducted. Self-efficacy was positively associated with time adherence and inversely correlated with acknowledged nonadherence. Self-efficacy mediated the relationship between need for social support and acknowledged nonadherence.
Catz, et al. (2000)	NR	Living with HIV	Longitudinal	USA, Wisconsin	72 PLWH; 87% men and 13% women; Race/ethnicity 36% African Americans, 56% Caucasians and 8% other	IV	Social support: Social Attachment subscale of the Social Provisions Scale; Self-efficacy: Treatment adherence self-efficacy; Uncategorized: Adherence self-promotion strategies	ML (I, Int)	ART adherence: self-reported ART Adherence	Low social support and low treatment adherence self-efficacy were associated with increased odds of missing medication doses. There were no significant differences in adherence self-promotion strategies between adherers and non-adherers to ART.
Trevino, et al. (2007)	NR	Living with HIV	Cross-sectional and longitudinal	USA, Washington DC, Pennsylvania and Ohio	429 PLWH; 85.5% male; Race/ethnicity: 52.7% African American and 47.3% Caucasian	IV	HIV Mastery: HIV/AIDS-Targeted Quality of Life scale; Social Support: Brief Interpersonal Support Evaluation; Spirituality/Religion: Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale Expanded, Duke Religion Index, and Brief RCOPE; Self-esteem: Rosenberg Global Self-Esteem Scale	ML (I, Int)	CD4: Obtained from medical records	None of the resilience resources were predictive of CD4.
Colbert, et al. (2013)	NR	Living with HIV, health literacy	Cross-sectional	USA, Pennsylvania and Ohio	302 PLWH; 70.5% male and 29.5% female; Race/ethnicity: 41.4% White and 58.6% African American	IV, mediator	Self-Efficacy: HIV Self-Efficacy Scale for Medication Taking, beliefs subscale	I	Adherence: ART medication adherence measured using electronic event monitoring and a self-report daily diary	There was a signifcant positive association between medication-taking self-efficacy and medication adherence.
Ironson, et al. (2006)	NR	Living with HIV	Longitudinal	USA, NR	100 PLWH; 64% male and 36% female; Race/ethnicity: 27.3% Hispanic White, 29.3 White, non-Hispanic; 38.4% African American, 5.1% other	IV	Religiousness/Spirituality: Increase in religioussness/spirituality after finding out about HIV+ status measure and at various times in one’s life measure; Social Support: ENRICHD Social Support Instrument; Coping- COPE; Optimism - Life Orientation Test; Proactive behavior: E.g., fighting spirit, self-initiated action-oriented behavior	ML (I, Int)	Disease progression: CD4 and viral load obtained by blood draws	Increase in religiousness/spirituality and church attendeance predicted greater preservation of CD4 over time. Increase in religiousness/spirituality predicted lower increase in viral load over time.
Ironson, et al. (2005)	NR	Living with HIV	Longitudinal	USA, NR	177 PLWH; 30% female and 70% male; 31% White, 36% African American, 28% Hispanic, 5% Other	IV and mediator	Optimism - Life Orientation Test (LOT) and the LOT-R; Coping - COPE scale; Proactive behavior: Self-reports of proactive behavior (e.g., fighting spirit, self-initiated action-oriented behavior)	I	Disease progression: CD4 and viral load obtained from blood draws	Optimism at baseline predicted increases in CD4 over 2 years and slower viral load increase. Proactive coping, depression, and avoidant coping mediated the relationship between optimism and CD4 change. Depression and avoidant coping also mediated the relationship between optimism and viral load.
Cha E, et al., (2008)	NR	Living with HIV and depression	Cross-sectional	USA, NR	215 PLWH; 64.7% male; Race/ethnicity: 62.3% White	IV, mediator, and outcome variable	Social support: Interpersonal Support Evaluation List; Self-efficacy: HIV Medication-Taking Self-Efficacy Scale	ML (I, Int)	ART adherence: Morisky Self-Report Medication Taking Scale	When each study hypothesis was examined separately: (1) low medication taking self-efficacy partially mediated the relationship between greater depressive symptoms and low medication adherence; (2) There was only an indirect effect of perceived social support on medication adherence via medication taking self-efficacy; and (3) depressive symptoms partially mediated the association between social support and medication taking self-efficacy
Harzke, et al. (2004)	NR	Living with HIV among drug users	Cross-sectional	USA, NR	137 PLWH; 100 men and 37 women; Race/ethnicity: 100% African American	IV	Social Support: Perceived Social Support scales; Impact of ART on feelings about HIV/AIDS: positive emotions scale; Relationship with care provider: Perceived quality of relationship with primary care provider	ML (I, Int)	Adherence: Self-reported adherence to ART	None of the resilience measures were associated significantly with ART adherence.
Leserman, et al. (2002)	NR	Living with HIV	Longitudinal	USA, North Carolina	96 PLWH, 100 male Race/ethnicity: 78% white; 22% non-white	IV	Social support - Sarason Brief Social Support Questionnaire	Int	HIV disease progression: Blood draws to obtain lymphocyte subsets (e.g., CD4) to determine CDC defined AIDS, clinical AIDS, and mortality	Lower cumulative average social support was predictie of higher risk of HIV disease progression as measured via the CDC classification and clinical condition.
Reif et al. (2013)	NR	HIV, substance use, and mood disorder	Cross-sectional	USA, North Carolina	154 PLWH; 64% Male, 36% Female, 1% Transgender; race/ethnicity: 82% African American, 13% Caucasian, 5% Multiracial, 2% Hispanic	IV and moderator	Self-efficacy - HIV Self-efficacy Questionnaire	I	Adherence: Center for Adherence Support Evaluation (CASE) Adherence Index for medication adherence	Combined HIV self-efficacy was associated positively with ART adherence. Among participants with a mood disorder, higher combined HIV self-efficacy was associated with greater adherence to HIV medication. Among those without a mood disorder, there was no significant relationship between combined HIV self-efficacy and ART adherence.
McCoy, et al (2009)	NR	Living with HIV and alcoholism	Cross-sectional	USA, North Carolina	216 PLWH; 40.3% women and 59.7% male; 70.4% Black, 21.3% White, 8.3% other	IV	Social support: modified Medical Outcomes Study Social Support Scale	Int	Time from HIV diagnosis until entry into care: obtained from state and medical records	The relationship between low positive social interaction and delayed time to care was moderated by history of alcoholism.
Berg, et al. (2004)	NR	Living with HIV among substance users	Longitudinal	USA, New York	113 PLWH; 43% female and 57% male; Race/ethnicity: 66% Hispanic, 22% African American and 12% White	IV	Social support: Social network measure adapted to include HIV-specific factors	ML (Int, C)	ART adherence: Medication event monitoring systems caps record	Not belonging to any HIV support groups was associated with worse adherence for both men and women.
Marshall, et al. (2013)	NR	Living with HIV	Cross-sectional	USA, Maryland, Michigan, New York, and Oregon	433 PLWH;: 66% male; Race/ethnicity: 58.7% African American, 24.3% White, 14.3% Latino, 2.8% other	IV	Patient activation: Patient Activation Measure (e.g., self-efficacy, locus og control)	I	Adherence: Self-reported ART; CD4 and viral load: Obtained from medical records	Higher patient activation score was associated significantly with CD4 count > 200 cells/mL and viral suppression. ART adherence partially mediated the association between patient activation and viral suppression.
Murphy, et al. (2004)	NR	Living with HIV	Cross-sectional	USA, Los Angeles County, California	115 PLWH; Men and women (breakdown NR); Race/ethnicity: 50% African American/Black; 24% White/Caucasian; 20% Latino/Hispanic; 2% Asian/Pacific Islander/ 2% Native American; Alaska Native; 2% mixed race/ethnicity	IV	Social support - Social Provisions Scale; Provider-patient relationship	Int	Adherence - modified AACTG ART adherence measure and dose and schedule adherence	Associations of social provisions subscales on ART adherence were mixed. The social attachment subscale was inversely associated with three-day adherence, overall social support was inversely associated with past week adherence whereas reliable reliances with others susbscale was positively associated with past week adherence. Finally, reassurance of worth was positively related to past month adherence. Participants with better communication with providers was positively associated with three-day adherence.
Wolf, et al. (2007)	NR	Literacy	Cross-sectional	USA, Illinois and Louisiana	204 PLWH; 79.9% Male; Race/Ethnicity: 45.1% African American	Mediator	Self-efficacy: Patient Medication Adherence Questionnaire to properly take and manage HIV medication	I	Adherence: Patient Medication Adherence Questionnaire	Low medication self-efficacy mediated the relationship between low literacy and medication nonadherence.
Colasanti J, et al. (2017)	NR	Living with HIV	Retrospective case-control study	USA, Georgia	59 PLWH; 32% female; Race/ethnicity: 88% African American	DV	Self-efficacy: General Self-Efficacy Scale; Social support: Multidimensional Scale of Perceived Social Support; Resilience: Connor-Davidson Resilience Scale	ML (I, Int)	Retention in HIV Care	Resilience and self-efficacy scores did not sgnificantly differ between continuously retained and unretained groups. Higher social support was observed among the continuously retained group compared to the unretained group.
Weaver, et al. (2005)	NR	Negative Mood	Longitudinal	USA, Florida	322 PLWH: 188 men and 134 women; Race/ethnicity: 59.9% African American, 22.8% non-Hispanic White, and 12.5% Latino/Hispanic.	Exogenous and endogenous variable	Social Support: Interpersonal Support Evaluation List; Coping: COPE Inventory	ML (I, Int)	Adherence: ACTG measure of ART adherence and MEMS cap data; Viral load: Obtained via blood draws	Social support was not directly related to adherence. The effects of social support on adherence were mediated by avoidance-oriented coping such that lower social support was associated with greater avoidance coping. In turn, avoidance-oriented coping was related to lower medication adherence, and in turn, higher viral load. Approach-oriented coping was not predictive of ART adherence.
Waldrop-Valverde, et al. (2014)	NR	Low health literacy and HIV-associated cognitive Impairment	Longitudinal	USA, Florida	210 PLWH; 52.8% female, 0.95% transgender, 46.1% male; Race/ethnicity: 82.86% Black or African American, 10.48% Hispanic, 4.29% White Non-Hispanic, 0.95% American Indian o Alaska Native, 1.43% Other	IV, moderator	Social Support: Social Support Questionnaire (support since becoming HIV positive); Patient-Provider Communication: Attitude Toward HIV Health Care Providers Scale and the Engagement with Health Care Providers Scale	Int	Adherence: Attendance at scheduled HIV care outpatient visits obtained via medical records	Individuals with cognitive impairment who had greater use of social support were less likely to miss medical visits.
Attonito, et al. (2014)	NR	Neurocognitive impairment and substance use	Cross-sectional	USA, Florida	246 PLWH: 66% were male; Race/ethnicity: 77.3% Black and 14.9% White, and 13.5% reported Hispanic ethnicity	IV	Social support: Medical Outcomes Study tangible support subscale	Int	Viral load: participant provided documentation	Social support was not directly related to viral load; thus, ART adherence did not mediate this relationship. However, a signficant path of marijuana use moderating the relationship between social support and viral load was evidenced.
Williams, et al. (1997)	NR	Living with HIV	Cross-sectional	USA, Connecticut	92 mothers living with HIV; 100% female; Race/ethnicity: 19% Hispanic, 56% African American, 24% White and 1% other	DV	Social Support: Norbeck Social Support Questionnaire	Int	Use of healthcare services: Self-report and medical chart review	There were no significant differences in entire network social support between mothers who did not delay care and those who did delay care. There were also no significant differences in social support specific to network members aware of the mother’s HIV status.
Cook, et al. (2017)	NR	Living with HIV	Longitudinal	USA, Colorado	53 PLWH; 75.5% male; 45.3% White, 26.4% Latino/Latina, 15.1% African American, 3.8% Native American, 3.8% Multiracial, 5.7% other/unspecified;	IV	Control Beliefs: Diary of Ambulatory Behavioral States Control Beliefs Scale and the Adherence Attitude Inventory; Coping: Assessment of Daily Coping Scale and Brief COPE; Social Support: Diary of Ambulatory Behavioral States Scale and Multidimensional Scales of Perceived Social Support	ML (I,Int)	Adherence: ART Adherence using Medication Event Monitoring System	Trait-level control beliefs had direct effects on daily ART adherence.
Cook, et al. (2017)	NR	Living with HIV	Longitudinal	USA, Colorado	87 PLWH: 68 men and 19 women. Race/ethnicity included White (43), Latino/a (21), African American (15), Native American (5), and Other/Unknown (3)	IV	Coping: Assessment of Daily Coping; Control beliefs: Diary of Ambulatory Behavioral States; Social Support: Diatry of Ambulatory Behavioral States	ML (I, Int)	Adherence: ART Adherence using Medication Event Monitoring System	Control beliefs and social support had indirect effects on ART adherence via motivation.
Bogart, et al. (2015	NR	Living with HIV and HIV enacted stigma	Longitudinal	USA, California	147 PLWH; 24% female and 5% transgender; Race/ethnicity 100% Black	IV and moderator	Social support: MOS Social Support Survey and Social Network Assessment	ML (Int, C)	Adherence: Medication Event Monitoring System was used to measure medication adherence.	Neither measure of social support was significantly associated with ART adherence. However, the interaction of structural social support with stigma significantly related to ART aderence such that there was an inverse association between stigma and adherence for participants who decreased the frequency of their interactions with people in their social network.
Milam et al. (2004)	NR	Living with HIV	Longitudinal	USA, California	412 PLWH; 88.1% male; Race/ethnicity: 38.8% White, 40.3% Hispanic, 14.8% African American, 6.1% Other	IV	Optimism - Life Orientation Test Revised	I	Viral load and CD4 counts - medical records ART adherence - self-report	There was a curvilinear relationship between optimism at baseline and CD4 counts at follow-up; those with moderate levels of optimism had the highest CD4 counts. Higher optimism was associated with greater likelihood of achieving 95% or higher ART adherence. ART adherence did not mediate the effects of optimism on CD4.
Johnson, et al. (2006)	NR	Living with HIV	Cross-sectional	USA, California	551 PLWH; 2.4% transgender, 16.5% female, 80.8% male; 32.5% Black/African American, 6.3% Hispanic/Latino, 51.6% White, 9.6% Other	Exogenous and endogenous variables	Social support - Social Provisions Scale; Positive affect: Positive States of Mind Scale; Social Problem-Solving: Social Problem Solving Inventory Revised	ML (I, Int)	Adherence: Self-reported ART Adherence ACTG measure	There was an indirect effect of social problem solving on ART adherence via psychological health (e.g., social provisions scale, positive states).
Huynh, et al. (2013)	NR	Living with HIV	Cross-sectional	USA, California	202 PLWH; 49% female, 1% transgender, 50% male; Race/ethnicity: 56% African American, 28% White, 10% Latino, 6% other	IV	Social support - Medical Outcome Study Social Support Survey	Int	Adherence: Self-reported ART adherence via the HIV Cost and Services Utilization Study measure	Social support was significantly positively associated with optimal ART adherence; however, this relationship was no longer significant once mental health symptoms were entered into the model.
Power, et al. (2003)	NR	Living with HIV	Cross-sectional	USA, California	73 PLWH; 53% male, 47% female; Race/ethnicity: 23% African American, 4% Asian American, 60% Caucasian, 10% Hispanic and 3% other	IV	Social support: UCLA Social Support Inventory;	Int	Adherence - ACTG Medication Adherence	Only social support from one’s partner was significantly associated with lower odds of missing medication doses.
Turan, et al. (2016)	NR	Living with HIV; psychosocial factors (e.g., stigma, avoidance coping, attachment related anxiety)	Cross-sectional	USA, Alabama	109 PLWH; 100% male; Race/ethnicity: 59 Black and 50 White	IV	Self-efficacy: HIV Treatment Adherence Self-Efficacy Scale and experience sampling method measure of HIV treatment self-efficacy; Coping: revised Ways of Coping List; Social Support: Interpersonal Support Evaluation List-Short Form and experience sampling method measure of HIV-related social support	ML (I, Int)	HIV visit adherence, viral load, and CD4: Obtained from clinic records; ART Adherence: Self-reported adherence to ART	Average HIV treatment self-efficacy (measured via experience sampling method), predicted greater odds of medication adherence, high CD4 count, and suppressed viral load, and predicted higher visit adherence. Among PLWH with higher avoidance coping with HIV, psychosocial stressors and recent social support predicted higher current treatment self-efficacy (as measured via experience sampling method).
Nokes, et al. (2012)	NR	Living with HIV	Cross-sectional	USA (10 states) and Puerto Rico	1414 PLWH: Gender - 71.1% male, 26.3% female and 2% transgender. Race/ethnicity - 4.3% Asian/Pacific Islander, 39.5% African American/Black, 24.3% Hispanic/Latino, 20% Native American, and 26.1% White/Anglo.	IV, mediator	Self-efficacy - HIV Adherence Self-Efficacy Scale (HIV-ASES); Social Capital - Social Capital Instrument (I, Int, C); Social Support - Perceived Social Support Measure	ML (I, Int, C)	ART Adherence: Visual Analog Scale for Medication Adherence and the 30-day Adherence Rating	HIV adherence self-efficacy was associated with ART adherence. Social support and social capital were also associated with adherence. In the model with all exposure variables, only HIV adherence self-efficacy retained significance.
Chen et al., (2013)	NR	Living with HIV	Cross-sectional	USA, Canada, Puerto Rico, Namibia, China	2,182 PLWH; 28.6% female, 70.3% men, and 2.4% transgender/gender queer; Race/ethnicity: 36.8% African/African-American, 21.4% White, 20.2% Hispanic, 16.1% Asian/Pacific Islander, and 3.1% Native American	IV and Outcome Variables	Self-efficacy: HIV Treatment Adherence Self-Efficacy scale; Self-esteem: Rosenberg self-esteem scale; Engagement with Health Care Providers: Engagement with Health Care Providers Scale	ML (I, Int)	ART adherence: ACTG HIV medication adherence measure	Medication adherence self-efficacy and ART adherence were positively related with higher health care provider engagement. Self-esteem was inversely associated with health care provider engagement.
Thornton, et al. (2000)	NR	Living with HIV	Longitudinal	United Kingdom, England	143 PLWH, 100% male; Race/ethnicity: 92% white	IV	Coping: Coping Orientations to Problems Experienced; Social Support: Interpersonal Support Evaluation List	ML (I, Int)	AIDS-Related Complex (ARC)/AIDS diagnosis: CD4 and Viral Load obtained from blood samples and medical records	Compared to men scoring in the upper tertile of the COPE acceptance scale, the risk of ARC or AIDS was nearly 5 times higher for men scoring in the lower tertile
Södergård, et al. (2006)	NR	Living with HIV	Cross-sectional	Sweden	946 PLWH: 63.4% male; Race/ethnicity NR	IV	Social support: social support for medication-taking	Int	Adherence - Self-reported ART adherence via Morisky Medication Adherence Scale	Social support for medication taking was not significantly related to medication adherence
Kekwaletswe, et al. (2017)	NR	Living with HIV	Cross-sectional	South Africa	304 PLWH; 98 males and 205 females; Race/ethnicity: NR	Exogenous and endogenous variables	Self-efficacy - HIV Treatment Adherence Self-Efficacy Scale; Social support - Medical Outcomes Study (MOS) Social Support Survey	ML (I, Int)	Adherence: Self-reported ART adherence ACTG measure, CASE Adherence Index, and 1 month adherence	Social support was positively associated with ART adherence via a direct path. An indirect positive relationship between social support and ART adherence also existed by way of depression and self-efficacy beliefs. Self-efficacy beliefs fully mediated the relationship between depression and ART adherence. Adherence self-efficacy beliefs partially mediated the relationship between alcohol use and ART adherence.
Wouters, et al. (2009)	NR	Living with HIV	Longitudinal	South Africa	268 PLWH; 34.7% male	IV	Social support: having a treatment buddy, having a community health worker, and participation in HIV/AIDS support group	ML (Int, C)	CD4 and viral load: Obtained from medical records	All three types of support were associated with higher CD4 cell count and viral suppression at 6, 12, and 24 months.
Tomakowsky, et al. (2001)	NR	Living with HIV	Cross-sectional and longitudinal	NR	78 PLWH; 100% male; Race/ethnicity 69.2% Caucasian and 30.6% African American	IV and mediator variable	Optimism: Explanatory style optimism - Expanded Attributional Style Questionnaire and Dispositional style optimism - Life Orientation Test; Coping: The COPE scale	I	CD4: CD4 counts obtained from blood samples and medical records	In cross-sectional analyses, explanatory style optimism was inversely associated with CD4. Prospective analyses indicated that explanatory style optimism was associated with decline in CD4 counts at 2-year follow-up. Coping was not related to explanatory optimism or baseline/follow-up CD4 counts
Kremer, et al. (2013)	NR	Living with HIV	Longitudinal	NR	177 PLWH; 30% female; Race/ethnicity 36% African American, 31% White (non-Latino), 28% Latino;	IV	Compassionate Love (Giving, Receiving, Self): Coding of transcripts and assignment of Likert Scale ratings.	ML (I,Int)	Adherence: Self-reported ART Adherence ACTG measure; CD4 and Viral Load: Obtained fom blood.	Compassionate love directed towards oneself was associated with undetectable VL at baseline, predicted 4-year cumulative undetectable viral load (was n.s. after controlling for compassionate love receiving), and predicted CD4 preservation after controlling for compassionate love giving.
Afolabi, et al. (2013)	NR	Living with HIV	Cross-sectional	Nigeria	379 PLWHA; 60.7% female and 39.3% male; Race/ethnicity: 86.3% Yoruba	DV	Social Support: Perceived Social Support-Family Scale; Family Functioning: Family Adaptability, Partnership, Growth, Affection, and Resolve (APGAR) measure	Int	Adherence: Self-reported adherence to HAART and pharmacy pill count	Compared to PLWH who were non-adherent to ART, those who were adherent to ART had normal family functioning APGAR scores and stronger perceived social support.
Poudel, et al. (2015)	NR	Living with HIV	Cross-sectional	Nepal	233 PLWH: 52.4% male and 47.6% female. Race/ethnicity NR	IV	Social Support - Nepali Family Support and Difficulty Scale	Int	Adherence - Self-reported ART adherence	Compared to those with low levels of emotional support from familyt, medium and high levels were associated with lower risk of ART nonadherence.
Sagarduy. et al. (2017)	NR	Living with HIV	Cross-sectional	Mexico	172 people living with HIV; 61.6% male and 38.4% female; Race/Ethnicity: NR	Endogenous variable	Social Support: Duke-UNC Functional Social Support Questionnaire adapted for Mexico	Int	ART adherence: Psychological Variables and Adherence Behaviors Questionnaire; CD4 and Viral Load: Obtained from medical redords	Social support was not associated with the hypothesized endogenous variable, medication adherence, and was thusly excluded from analyses.
Zachariah, et al. (2007)	NR	Living with HIV	Longitudinal	Malawi	1634 PLWH; 65% female and 35% male	IV	Community Support - Community activities linked to HIV care (e.g., patient referrals, defaulter tracing, community centers, support to family carers)	C	Adherence and CD4 count: Obtained by review of patient master cards and ART patient register	PLWH in areas with greater community support were more likely to be alive and on ART and had higher CD4 count.
Peltzer, et al. (2010)	NR	Living with HIV	Cross-sectional	South Africa	519 PLWH: 26.6% male and 73.4% female. Ethnicity - 98.8% Zulu and 1.2% Other	IV	Social Support - Social Support Questionnaire; Spirituality - the Spirituality subscale of the WHOQOLHIV BREF	ML (I, Int)	ART adherence - 30-day Visual Analog Scale; the AACTG adherence measure	Higher social support scores was associated with higher odds of medication adherence (Visual Analog Scale). Spirituality/religion/personal beliefs were associated with lower odds of medication adherence Visual Analog Scale).
Kamau, et al. (2011)	NR	Living with HIV	Cross-sectional	Kenya	354 PLWH; 71.47 women; Race/ethnicity: NR	IV	Coping Self-Efficacy: Coping Self-efficacy Survey	ML (I, Int)	Adherence: Self-reported ART Adherence ACTG measure	Coping Self-Efficacy was positively and significantly associated with ART adherence. However, only the “stop unpleasant emotions and thoughts” coping self-efficacy subscale had a statistically significant association with ART adherence.
Kioko, et al. (2017)	NR	Living with HIV	Cross-sectional	Kenya	301 PLWH; 37.2% Male, 62.7% Female; Race/Ethnicity: NR	IV	Social support -Perceived Social Support (measured at the interpersonal and community levels)	ML (Int, C)	Aherence: Self-reported ART adherence and pill count	In the full model, perceived social support was not significantly associated with increased odds of adherence.
Pandey, et al. (2017)	NR	Living with HIV	Cross-sectional	India, Chhattisgarh	200 PLWH	Exogenous and endgenous	Hardiness - Psychological Hardiness Scale; Social suport - Social Support Scale	ML (I, Int)	CD4 - CD4+ T- lymphocyte count	Hardiness was associated positively with CD4. Social support partially mediated the relationship between hardiness and CD4 cell count.
Luszczynska, et al. (2007)	NR	Living with HIV	Cross-sectional	India	104 PLWH; 63.5% female; Race/ethnicity: NR	IV, mediator	Social support- Berlin Social Support Scales; Self-efficacy - General self-efficacy scale; Finding benefit in being an HIV patient: Benefit Finding Scale	ML (I, Int)	Adherence: Self-reported adherence to ART	Self-efficacy was directly related to adherence; benefit finding partially mediated this relationship. Self-efficacy also mediated the relationship between social suport and adherence.
Mo, et al. (2009)	NR	Living with HIV	Longitudinal	Hong Kong	102 PLWH: 87.3% male, 12.7% female. Race/ethnicity NR	DV	Adherence self-efficacy - Adult AIDS Clinical Trial Group (AACTG) Adherence Measure). Coping - Brief COPE;	I	Adherence - Self-reported ART adherence using the AACTG adherence measure	Compared to participants who were classified as unintentional or intentional non-adherers all adherers to ART had high adherence self-efficacy.
Molassiotis, et al. (2002)	NR	Living with HIV	Cross-sectional	Hong Kong	136 PLWH; 92.5% male and 7.5% female Race/ethnicity: 88.3% Chinese, 9.6% Caucasian, and 2.2% Thai/Indian	IV	Multidimensional Health Locus of Control Scale; Mental Adjustment to HIV Scale (coping and adjustment to HIV); Adherence self-efficacy; Family/friends support for medication taking	ML (I, Int)	Adherence - Self-reported ART adherence using the AACTG and additional study-specific adherence questions	Predictors of adherence included high self-efficacy, more internal health locus of control, denial-avoidant coping, and less family support for remembering to take medication.
Safren, et al. (2014)	NR	Living with HIV	Longitudinal	Haiti, USA, Brazil, India, Malawi, Peru, South Africa, Thailand and Zimbabwe	1568 PLWH; 52.9% male and 47.1% female; Race/ethnicity NR	IV	Social support: general satisfaction with social support	Int	Adherence: Medication adherence via ACTG QOL061 adherence questionnaire and pill counts; Viral Load (treatment failure) - HIV-1 RNA	In multivariable analyses, satisfaction with social support was not predictive of medication non-adherence, pill count, or treatment failure.
Corless, et al. (2017)	NR	Living with HIV	Cross-sectional	Canada, Namibia, Thailand, USA and Puerto Rico	1811 PLWH; 71% male and 29% female; Race/ethnicity: 23.6% White	IV	Engagement with healthcare provider: Engagement with healthcare provider scale; Self-esteem: Rosenberg self-esteem scale; Social capital: revised Social capital scale; Sense of coherence: Sense of coherence scale; Self-efficacy: HIV adherence self-efficacy scale and Chronic disease self-efficacy scale; Self-compassion: Neff self-compassion scale	ML (I, Int, C)	Adherence: 30-day Visual Analog Scale for Medication Adherence	Higher self-efficacy scores were associated with lower odds of being in the non adherence (0%), low adherence, and medium adherence categories.
O’Cleirigh, et al. (2007)	Focus is on conscientiousness, with the hypothesis that it may be related to “slower disease progression”…”through greater resilience to distress (e.g., less catastrophic disease-related stressor appriasals and lower levels of depressive symptomatology).”	Living with HIV	Longitudinal	USA, NR	119 PLWH: 67% male; Race/ethnicity - 26.9% non-Hispanic White; 42% African American; 28.6% Hispanic; 2.5% other	IV, mediator	Conscientiousness: 12-item scale of the NEO-FFI (IV); Coping - Carver, Scheier, and Weintraub’s COPE scales (Mediator)	I	CD4 and Viral Load: Blood draws to obtain	Conscientiousness predicted significant increases in CD4 number and significant decreases in viral load at 1 year. Conscientiousness was related positively to active coping. Active coping did not mediate the relationship between conscientiousness and CD4 or viral load change
Pecoraro, et al. (2016)	“Resilience, the ability to resist negative psychological responses when confronted with stress or trauma.”	Living with HIV	Cross-sectional	Russia	240 PLWH: 58% male and 42% female. Race/ethnicity included 99% White	DV	Coping: Proactive Coping Inventory; Spirituality: The View of God Inventory	ML (I, Int)	Engaged-in-Care or Lost-to-Care. Care measures assessed by ART adherence and clinic attendance	PLWH Engaged-in-care (EICs) had higher proactive coping scores, social support, less avoidance coping, described themselves as more spiritual, had stronger spirituality/religious beliefs, and positive views of God and engaged in more spiritual/religious activities.
Dale, et al. (2014)	“A combination of personality characteristics and successful coping that allows an individual to function adaptively in the face of or following adversity.” ..”Process of bouncing back from an adversity, as an adaptive outcome…, and/or as a trajectory over time that consists of adaptive functioning.”	Living with HIV, abuse history (e.g., sexual, physical)	Cross-sectional	USA, Illinois	138 PLWH; 100% female; Race/ethnicity: 4.3% White/non-Hispanic, 4.3% White/Hispanic, 87% African-American/non-Hispanic, 0.7% African-American/Hispanic, 1.4% Other/Hispanic, 0.7% Asian/Pacific Islander, 0.7% Native American/Alaskan, 0.7% Other	IV	Resilience: Connor-Davidson Resilience Scale	I	Adherence: Self-reported ART adherence; HIV disease progression: CD4 count and HIV RNA load	Higher resilience scores were associated with increased odds of having ART adherence >/= 95% and having undetectable viral loads. The association between resilience and ART adherence was moderated by abuse histories. Resilience did not significantly relate to ART adherence for women without abuse histories.

NR = Not Reported; IV = Independent Variable; WHOQOLHIV BREF = World Health Organization Quality of Life HIV BREF; I = Individual Level; Int = Interpersonal Level; C = Community Level; ML = Multilevel; ART = antiretroviral